Endocrinology (all articles)
Real-time diabetic retinopathy screening by deep learning in a multisite national screening program: a prospective interventional cohort study.
29 Mar, 2022 | 08:17h | UTCInvited Commentary: Artificial intelligence deployment in diabetic retinopathy: the last step of the translation continuum – The Lancet Digital Health
M-A: Comparative effectiveness of statins on non-HDL cholesterol in people with diabetes and at risk of cardiovascular disease.
25 Mar, 2022 | 10:01h | UTCNews Release: Best statins for reducing cardiovascular risk in people with diabetes found – University of Manchester
Commentary on Twitter
This network meta-analysis indicated that rosuvastatin, at moderate and high intensity doses, and simvastatin and atorvastatin, at high intensity doses, were most effective at moderately reducing levels of non-HDL-C in patients with diabeteshttps://t.co/NwUf4sX5KA
— The BMJ (@bmj_latest) March 24, 2022
Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study.
25 Mar, 2022 | 09:56h | UTCCommentaries:
Sweeteners may be linked to increased cancer risk – new research – The Conversation
Expert reaction to observational study of sweeteners and cancer risk – Science Media Centre
Weight maintenance after dietary weight loss: systematic review and meta-analysis on the effectiveness of behavioral interventions.
25 Mar, 2022 | 08:41h | UTC
Consensus Statement | Minimally-invasive treatments for benign thyroid nodules: recommendations for information to patients and referring physicians.
24 Mar, 2022 | 08:42h | UTC
Position Paper | Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy.
24 Mar, 2022 | 08:34h | UTC
M-A: Global prevalence and trends in hypertension and type 2 diabetes mellitus among slum residents.
24 Mar, 2022 | 08:30h | UTC
Diabetic retinopathy for the non-ophthalmologist.
24 Mar, 2022 | 08:07h | UTCDiabetic retinopathy for the non-ophthalmologist – Clinical Medicine Journal
Cohort Study: Risks and burdens of incident diabetes in long COVID.
23 Mar, 2022 | 10:32h | UTC
Review: Diagnosis and management of secondary causes of steatohepatitis.
23 Mar, 2022 | 09:59h | UTCDiagnosis and management of secondary causes of steatohepatitis – Journal of Hepatology
Review: Testicular dysfunction among cancer survivors.
23 Mar, 2022 | 09:47h | UTC
RCT: Levothyroxine is not beneficial for euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss.
22 Mar, 2022 | 08:24h | UTCLevothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)
Commentary: Levothyroxine No Boon for Birth Rates in Women With Possible Thyroid Disorder – MedPage Today (free registration required)
RCT: Cocoa flavanol supplementation shows promise for the prevention of cardiovascular disease events.
18 Mar, 2022 | 08:54h | UTC
Commentary on Twitter (thread – click for more)
In @AJCNutrition: @HowardSesso, Dr. JoAnn Manson of @BWHDPM @BrighamWomens & colleagues report the main findings of the first ever randomized trial of a cocoa flavanol supplement on cardiovascular disease endpointshttps://t.co/0F5v8WqzdM and https://t.co/vA3wwT0Amw (1 of 5) pic.twitter.com/X08hiNUCzK
— BrighamResearch (@BrighamResearch) March 16, 2022
Expert panel guidance and narrative review of treatment simplification of complex insulin regimens to improve outcomes in Type 2 Diabetes.
18 Mar, 2022 | 08:15h | UTC
[News release – not published yet] Empagliflozin phase III EMPA-KIDNEY trial will stop early due to evidence of efficacy in people with chronic kidney disease.
17 Mar, 2022 | 09:07h | UTC
Commentary on Twitter
Details of the design & pt characteristics now published:
6609 people from 8 countries
(UK, Germany, Italy, USA, Canada, China, Malaysia, Japan)
Mean age 64 years
1/3 female
1/2 diabetes; 1/2 without
3/4 eGFR <45 mL/min/1.73 m2.
1/2 uACR <300 mg/g https://t.co/jOD8kyp3i4 pic.twitter.com/YYpGPJDnV9— Martin Landray (@MartinLandray) March 16, 2022
Italian guidelines for the treatment of type 2 diabetes.
16 Mar, 2022 | 10:06h | UTCItalian guidelines for the treatment of type 2 diabetes – Acta Diabetologica
Related:
Guideline: ADA 2022 Standards of Medical Care in Diabetes.
NICE Updated Guidance: Management of Type 2 Diabetes.
Recent updates to clinical practice guidelines for diabetes mellitus.
Review | Clinical application of intermittent fasting for weight loss: progress and future directions.
16 Mar, 2022 | 09:54h | UTCClinical application of intermittent fasting for weight loss: progress and future directions – Nature Reviews Endocrinology (if the link is paywalled, try this one)
Related:
M-A: Intermittent fasting and obesity-related health outcomes.
Intermittent fasting may be effective weight loss strategy in patients with type 2 diabetes
Systematic review: Intermittent fasting for the prevention of cardiovascular disease
Randomized trial: Effects of time-restricted eating in women and men with overweight and obesity
How good a diet is intermittent fasting?
Systematic Review: Intermittent Fasting and Weight Loss
Clinical Management of Intermittent Fasting in Patients with Diabetes Mellitus
Fasting Diets are Going Mainstream — Ahead of the Science. Here’s Why.
Commentary on Twitter
Just published – @DrKristaVarady and colleagues discuss the current evidence for the safety and efficacy of #intermittentfasting diets (£) https://t.co/nxDS0ZUzJd pic.twitter.com/bA6y0e7Xng
— Nature Reviews Endocrinology (@NatureRevEndo) February 25, 2022
Cohort Study | Breast arterial calcification: a novel cardiovascular risk enhancer among postmenopausal women.
16 Mar, 2022 | 09:56h | UTCBreast Arterial Calcification: a Novel Cardiovascular Risk Enhancer Among Postmenopausal Women – Circulation: Cardiovascular Imaging (link to abstract – $ for full-text)
News Release: Mammograms may provide clues about women’s risk for cardiovascular disease – AHA Newsroom
Commentaries:
More Evidence Links Breast Arterial Calcification and CVD Risk – TCTMD
Breast Arterial Calcification on Mammography Tied to CVD Risk – HealthDay
Related: Review: Role of Breast Arterial Calcification for Cardiovascular Risk Stratification in Women
M-A: Association of low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages with body weight and cardiometabolic risk.
16 Mar, 2022 | 09:49h | UTCCommentary: Alternative sweeteners in your drinks can help with weight and diabetes risk, study says – CNN
Commentary on Twitter
Meta-analysis of 17 trials found low-calorie sweetened beverages were associated with improvement in body weight and metabolic risk, suggesting they may be a viable alternative to water when replacing sugar-sweetened beverages in overweight & obese adults. https://t.co/coz3U4pIZA
— JAMA Network Open (@JAMANetworkOpen) March 14, 2022
Cohort Study: Patterns of early life weight gain and female onset of puberty.
16 Mar, 2022 | 08:46h | UTCPatterns of Early Life Weight Gain and Female Onset of Puberty – Journal of the Endocrine Society
Commentary: Early life weight gain predicts pubertal onset in girls – Healio
Case Series: Potential identification of Type 2 Diabetes with elevated insulin clearance.
16 Mar, 2022 | 08:49h | UTCPotential Identification of Type 2 Diabetes with Elevated Insulin Clearance – NEJM Evidence
Commentary on Twitter
In a case series of 101 patients from Japan with newly diagnosed Type 2 Diabetes Mellitus, about half the patients had elevated rates of metabolic insulin clearance. These data could describe a novel endotype of #T2DM. #CardioTwitter #EndoTwitter https://t.co/2UXal6N0hy pic.twitter.com/dEqMskG3qs
— NEJM Evidence (@NEJMEvidence) March 15, 2022
M-A: Evaluating the association between LDL Cholesterol reduction and relative and absolute effects of statin treatment.
15 Mar, 2022 | 10:04h | UTCEvaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary from the author: Benefits of statins may have been overstated – new study – The Conversation
Commentary on Twitter
Our study in @JAMAInternalMed asked 2 questions 1. Is reducing one’s ‘bad’ cholesterol was associated with a proportional reduction in death, heart attack and stroke? 2. What's the absolute reduction in risk from taking statins? https://t.co/Zwh7LmUD0e
— Dr Paula Byrne (@pbyrne82) March 14, 2022
Review | Resistance exercise as a treatment for sarcopenia: prescription and delivery.
15 Mar, 2022 | 09:55h | UTCResistance exercise as a treatment for sarcopenia: prescription and delivery – Age and Ageing
Cohort studies show an independent association of Lipoprotein(a) and coronary artery calcification with atherosclerotic cardiovascular risk.
15 Mar, 2022 | 08:28h | UTCIndependent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Practical, evidence-based approaches to nutritional modifications to reduce atherosclerotic cardiovascular disease.
14 Mar, 2022 | 01:25h | UTC